Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

Heart health experts released new guidance to help identify early risk factors for heart disease that go beyond tracking ...

The American Heart Association has released new cholesterol guidelines recommending earlier screening and treatment for ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.